TNSN96004A1 - Nouvelles applications d'un dimere de lysozyme - Google Patents
Nouvelles applications d'un dimere de lysozymeInfo
- Publication number
- TNSN96004A1 TNSN96004A1 TNTNSN96004A TNSN96004A TNSN96004A1 TN SN96004 A1 TNSN96004 A1 TN SN96004A1 TN TNSN96004 A TNTNSN96004 A TN TNSN96004A TN SN96004 A TNSN96004 A TN SN96004A TN SN96004 A1 TNSN96004 A1 TN SN96004A1
- Authority
- TN
- Tunisia
- Prior art keywords
- diseases
- lysozyme
- new applications
- dimer
- lysozyme dimer
- Prior art date
Links
- 102000016943 Muramidase Human genes 0.000 title abstract 3
- 108010014251 Muramidase Proteins 0.000 title abstract 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 title abstract 3
- 229960000274 lysozyme Drugs 0.000 title abstract 3
- 235000010335 lysozyme Nutrition 0.000 title abstract 3
- 239000004325 lysozyme Substances 0.000 title abstract 3
- 239000000539 dimer Substances 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000031295 Animal disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037824 growth disorder Diseases 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Fish Paste Products (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA PRESENTE INVENTION CONCERNE DES COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN DIMERE DE LYSOZYME, DE PREFERENCE DE PURETE ELEVEE, C'EST- A-DIRE, AYANT A PEU PRES 10% EN POIDS OU MOINS DE PRODUITS SECONDAIRES NON INTENTIONNELS, ET LEURS NOUVELLES APPLICATIONS. DE TELLES APPLICATIONS, COMPRENNENT UNE ADMINISTRATION LOCALE, ORALE ET PARENTERALE DESDITES COMPOSITIONS POUR UNE IMMUNOSTIMULATION NON SPECIFIQUE A TITRE DE MESURE D'EMPECHEMENT ET/OU DE TRAITEMENT THERAPEUTIQUE DE MALADIES HUMAINES ET ANIMALES, COMPRENANT LE CANCER, DES TROUBLES DE LA CROISSANCE DES CHEVEUX, DES MALADIES DES POISSONS ET DES MALADIES DES ABEILLES. LA STIMULATION NON SPECIFIQUE DU SYSTEME IMMUN EST INDUITE PAR UNE APPLICATION UNIQUE OU REPETEE DE LA COMPOSITION A BASE DE DIMERE DE LYSOZYME, DE PREFERENCE A DES CONCENTRATIONS DE 5 A 500 µ/KG DU POIDS CORPOREL.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95100446 | 1995-01-13 | ||
| EP95110638 | 1995-07-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN96004A1 true TNSN96004A1 (fr) | 2005-03-15 |
Family
ID=26138401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN96004A TNSN96004A1 (fr) | 1995-01-13 | 1996-01-11 | Nouvelles applications d'un dimere de lysozyme |
Country Status (37)
| Country | Link |
|---|---|
| EP (2) | EP1086703A3 (fr) |
| JP (1) | JPH10511974A (fr) |
| KR (1) | KR100420377B1 (fr) |
| CN (1) | CN1090506C (fr) |
| AP (2) | AP628A (fr) |
| AT (1) | ATE218367T1 (fr) |
| AU (1) | AU709620B2 (fr) |
| BA (1) | BA96074A (fr) |
| BG (1) | BG62239B1 (fr) |
| BR (1) | BR9606973A (fr) |
| CA (1) | CA2210091A1 (fr) |
| CZ (1) | CZ293353B6 (fr) |
| DE (2) | DE69621589D1 (fr) |
| DZ (1) | DZ1964A1 (fr) |
| EA (1) | EA001462B1 (fr) |
| EE (1) | EE9700154A (fr) |
| ES (1) | ES2109208T1 (fr) |
| FI (1) | FI972943A7 (fr) |
| GB (1) | GB2311724B (fr) |
| GE (1) | GEP20012571B (fr) |
| GR (1) | GR970300047T1 (fr) |
| HR (1) | HRP960014A2 (fr) |
| HU (1) | HU223903B1 (fr) |
| IL (1) | IL116737A (fr) |
| MA (1) | MA23775A1 (fr) |
| MD (1) | MD1633C2 (fr) |
| MY (1) | MY132437A (fr) |
| NO (1) | NO973203L (fr) |
| NZ (1) | NZ298432A (fr) |
| OA (1) | OA10436A (fr) |
| PL (1) | PL185678B1 (fr) |
| SK (1) | SK94297A3 (fr) |
| SV (1) | SV1996000001A (fr) |
| TN (1) | TNSN96004A1 (fr) |
| TR (1) | TR199700633T1 (fr) |
| UA (1) | UA50728C2 (fr) |
| WO (1) | WO1996021463A2 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6123937A (en) * | 1997-03-14 | 2000-09-26 | Nika Health Products, Limited | Applications of lysozyme dimer |
| ATE211389T1 (de) * | 1998-04-27 | 2002-01-15 | Nika Health Products Ltd | Zusammensetzung zur verbesserung der fruchtbarkeit und ihre verwendung |
| AUPP489798A0 (en) * | 1998-07-28 | 1998-08-20 | Mediko Pty Ltd | Hair growth/maintenance compositions and methods |
| WO2008109401A2 (fr) * | 2007-03-02 | 2008-09-12 | Saint Simeon Lda | Composition et procédé de traitement du virus de papillome et des sarcoïdes équins |
| CN103518978B (zh) * | 2013-10-22 | 2016-01-13 | 上海艾魁英生物科技有限公司 | 新型溶菌酶制剂及其制备方法 |
| CN105828829A (zh) * | 2013-12-18 | 2016-08-03 | 帝斯曼知识产权资产管理有限公司 | 用于含角蛋白的组织的包含溶菌酶水解物的组合物 |
| CN104585546B (zh) * | 2015-01-20 | 2019-02-05 | 上海海洋大学 | 一种促生长抗应激罗非鱼饲料及其制备方法 |
| CN105707509B (zh) * | 2016-01-25 | 2018-12-28 | 浙江艾杰斯生物科技有限公司 | 一种用于防治草鱼烂腮病的饲料添加剂 |
| WO2020099556A1 (fr) | 2018-11-14 | 2020-05-22 | Universiteit Antwerpen | Lysozyme oxydé |
| EP4003300A4 (fr) * | 2019-07-26 | 2023-06-28 | Infinant Health, Inc | Compositions nutritives contenant des protéines bioactives |
| CN111657407A (zh) * | 2020-05-14 | 2020-09-15 | 上海艾魁英生物科技有限公司 | 提高断奶仔猪非特异性免疫功能的饲料添加剂、其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5533408A (en) * | 1978-08-30 | 1980-03-08 | Eisai Co Ltd | Immunity-increasing agent |
| JPS5543040A (en) * | 1978-09-25 | 1980-03-26 | Eisai Co Ltd | Immunity raising agent |
| DE3230999A1 (de) * | 1982-08-20 | 1984-02-23 | Philips Kommunikations Industrie AG, 8500 Nürnberg | Verfahren zur zugriffssteuerung bei einem nachrichtensystem |
| EP0181634A3 (fr) * | 1984-11-14 | 1987-09-09 | Takeda Chemical Industries, Ltd. | Gène synthétique pour lysozyme humaine |
| RU2061496C1 (ru) * | 1985-08-02 | 1996-06-10 | Институт общей патологии и экологии человека | Средство, стимулирующее эритропоэз |
| WO1988005783A1 (fr) * | 1987-01-28 | 1988-08-11 | Ortho Pharmaceutical Corporation | Peptides immunodepresseurs et leurs procedes d'utilisation |
| HU204710B (en) * | 1988-05-26 | 1992-02-28 | Nika Health Products Inc | Process for producing pharmaceutical compositions having antiviral and antibacterial effect |
| ES2086403T3 (es) * | 1990-01-08 | 1996-07-01 | Nika Health Products Ltd | Procedimiento para la elaboracion de dimeros de ribonucleasa. |
| MC2243A1 (fr) * | 1990-01-08 | 1993-02-23 | Nika Health Products Ltd | Procede de preparation de dimeres de la ribonuclease |
| PL173978B1 (pl) * | 1992-07-13 | 1998-05-29 | Nika Health Products Ltd | Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej |
| RU2082413C1 (ru) * | 1993-06-30 | 1997-06-27 | Нижегородский государственный медицинский институт | Способ лечения язвенной болезни двенадцатиперстной кишки |
| RU2071339C1 (ru) * | 1994-07-25 | 1997-01-10 | Щербакова Элеонора Григорьевна | Средство для лечения и профилактики дисбактериоза |
| RU2123345C1 (ru) * | 1997-07-31 | 1998-12-20 | Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук | Средство для лечения дисбактериоза |
-
1996
- 1996-01-10 DZ DZ960005A patent/DZ1964A1/fr active
- 1996-01-11 IL IL11673796A patent/IL116737A/xx not_active IP Right Cessation
- 1996-01-11 TN TNTNSN96004A patent/TNSN96004A1/fr unknown
- 1996-01-12 AP APAP/P/1996/000783A patent/AP628A/en active
- 1996-01-12 SV SV1996000001A patent/SV1996000001A/es unknown
- 1996-01-12 MY MYPI96000118A patent/MY132437A/en unknown
- 1996-01-12 BA BA960074A patent/BA96074A/bs unknown
- 1996-01-12 HR HR95110638.4A patent/HRP960014A2/hr not_active Application Discontinuation
- 1996-01-13 AU AU43916/96A patent/AU709620B2/en not_active Ceased
- 1996-01-13 EA EA199700101A patent/EA001462B1/ru not_active IP Right Cessation
- 1996-01-13 GE GEAP19963815A patent/GEP20012571B/en unknown
- 1996-01-13 AT AT96900321T patent/ATE218367T1/de not_active IP Right Cessation
- 1996-01-13 SK SK942-97A patent/SK94297A3/sk unknown
- 1996-01-13 NZ NZ298432A patent/NZ298432A/en unknown
- 1996-01-13 CZ CZ19972202A patent/CZ293353B6/cs not_active IP Right Cessation
- 1996-01-13 EE EE9700154A patent/EE9700154A/xx unknown
- 1996-01-13 UA UA97063430A patent/UA50728C2/uk unknown
- 1996-01-13 JP JP8521448A patent/JPH10511974A/ja active Pending
- 1996-01-13 MD MD97-0244A patent/MD1633C2/ro unknown
- 1996-01-13 DE DE69621589T patent/DE69621589D1/de not_active Expired - Lifetime
- 1996-01-13 KR KR1019970704726A patent/KR100420377B1/ko not_active Expired - Fee Related
- 1996-01-13 FI FI972943A patent/FI972943A7/fi unknown
- 1996-01-13 DE DE0804227T patent/DE804227T1/de active Pending
- 1996-01-13 CA CA002210091A patent/CA2210091A1/fr not_active Abandoned
- 1996-01-13 TR TR97/00633T patent/TR199700633T1/xx unknown
- 1996-01-13 AP APAP/P/1997/001024A patent/AP871A/en active
- 1996-01-13 CN CN96192331A patent/CN1090506C/zh not_active Expired - Fee Related
- 1996-01-13 EP EP00124590A patent/EP1086703A3/fr not_active Withdrawn
- 1996-01-13 ES ES96900321T patent/ES2109208T1/es active Pending
- 1996-01-13 GB GB9714354A patent/GB2311724B/en not_active Expired - Fee Related
- 1996-01-13 EP EP96900321A patent/EP0804227B1/fr not_active Expired - Lifetime
- 1996-01-13 PL PL96321546A patent/PL185678B1/pl not_active IP Right Cessation
- 1996-01-13 BR BR9606973A patent/BR9606973A/pt not_active Application Discontinuation
- 1996-01-13 WO PCT/EP1996/000135 patent/WO1996021463A2/fr not_active Ceased
- 1996-01-13 HU HU9801689A patent/HU223903B1/hu not_active IP Right Cessation
- 1996-01-15 MA MA24130A patent/MA23775A1/fr unknown
-
1997
- 1997-06-30 BG BG101709A patent/BG62239B1/bg unknown
- 1997-07-10 NO NO973203A patent/NO973203L/no not_active Application Discontinuation
- 1997-07-11 OA OA70048A patent/OA10436A/en unknown
- 1997-12-31 GR GR970300047T patent/GR970300047T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV12766A (lv) | Composition of l-dopa esters | |
| EP0359783A4 (fr) | Traitement de maladies auto-immunitaires par administration orale d'auto-antigenes. | |
| MA26757A1 (fr) | Preparation pharmaceutique de moxifloxacine | |
| TNSN96004A1 (fr) | Nouvelles applications d'un dimere de lysozyme | |
| WO1982001821A1 (fr) | Composition pharmaceutiques antimycotiques synergiques et leur procede de preparation | |
| RU2000132310A (ru) | Применение продуктов на основе магния для лечения или профилактики опухолевых и аутоиммунных заболеваний | |
| EP0308197A3 (fr) | Méthode pour stimuler le système immunitaire | |
| BR9607541A (pt) | Tratamento de doenças que tem por causa o fator de crescimento da citoquina | |
| US5989574A (en) | Weight loss compound and method of using | |
| DE3263832D1 (en) | Gallium chloride, an anti-cancer drug | |
| FR2393579A1 (fr) | Agent antiviral et son application au traitement des affections virales | |
| ES8707111A1 (es) | Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas. | |
| ZA963784B (en) | Terpenoidic derivatives useful as antitumor agents. | |
| Csato et al. | Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis | |
| EG17992A (en) | Preparation of a medicament for arthritis and theumatism | |
| US5904926A (en) | Weight loss compound and method of using | |
| MX9705246A (es) | Nuevas aplicaciones de dimero de lisozina. | |
| SU1029451A1 (ru) | Антибактериальное средство | |
| JO1898B1 (en) | New uses of the partial formula partial lysozyme | |
| YU896A (sh) | Farmaceutski sastav sa sadržajem lizozomskog dimera | |
| MX9707394A (es) | Formulaciones de ridogrel de dosis baja y su uso para el tratamiento de enfermedades intestinales inflamatorias. | |
| Oster et al. | Amifostine—protection from hematotoxicity and nephrotoxicity induced by chemotherapy | |
| TH23121A (th) | การประยุกต์แบบใหม่ของไลโซไซม์ ไคเมอร์ | |
| Rollinger-Holzinger et al. | Expression and cloning of LST-1: A novel gene in the human TNF region | |
| Multhoff et al. | Differential effects of an ifosfamide treatment on intracellular glutathione (GSH) levels of lymphocyte subsets correlates with immunological functions |